Monoclonal Antibody Therapeutics In-Depth Industrial and Market studies - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2024
 |
| Monoclonal Antibody Therapeutics |
Albany, New York, Mar 07, 2017
"Monoclonal
Antibody Therapeutics Market - Global Industry Analysis, Size, Share,
Volume, Growth, Trends, and Forecast 2017 - 2024"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Global
Monoclonal Antibody Therapeutics Market: Overview
Monoclonal antibodies are a type of biological
therapy used in the treatment serious conditions such as cancer,
rheumatoid arthritis, Crohn’s diseases, psoriasis, osteoporosis,
systemic lupus erythematous, and others. Monoclonal antibody are
target specific in action by not affect the other cells of the body
thus restores the immune system.
The
market report comprises an elaborated executive summary, which
includes market snapshot that provides information about various
segments of the market. It also provides information and data
analysis of the market with respect to market segments based on
application, source, end-user, and geography. The market overview
section of the report analyzes market dynamics such as drivers,
restraints and opportunities that influences the monoclonal antibody
therapeutics market in the current and future scenario.
– Global Monoclonal Antibody
Therapeutics Market: Segmentation
This report analyzes the current and future
prospects of the monoclonal antibody therapeutics market based on
type of application, source, end user and geography. By application
monoclonal antibodies are segmented according to the therapeutic area
such as cancer, autoimmune diseases, infection, hematological
diseases, ophthalmological diseases and others which include
monoclonal antibodies used in treating cardiovascular, respiratory,
and orthopedic disorders as well as monoclonal antibodies used in the
prevention of transplant rejection.
By source monoclonal antibodies are segmented into
human, humanized, chimeric, and others, which include peptide body
and murine antibodies. The human monoclonal antibody segment is
expected to be highest contributing segment in the monoclonal
antibody therapeutic market during the forecast period. Various
factors such as patent expiry of block buster drugs, robust pipeline
of monoclonal antibodies indicated in the treating various types of
cancer and other disorders such as hematological, cardiovascular and
orthopedic and upcoming biosimilars, define the market growth over
the forecast period.
– Global Monoclonal Antibody
Therapeutics Market: Research Methodology
The research is a combination of primary and
secondary research, conducted for understanding and arriving at
trends, used to forecast the expected revenue of the major monoclonal
antibody therapeutics market in the near future. Primary research
formed the bulk of our research efforts with information collected
from in-depth interviews and discussions with a number of key
industry experts and opinion leaders. Secondary research involved
study of company websites, annual reports, press releases, investor
presentations, analyst presentation and various international and
national databases.
The report provides estimated market size in terms
of US$ Mn for each by application, source, end user, and geography
for the period 2014 to 2024, considering the macro and micro
environmental factors. The revenue generated from each product was
calculated by considering number of products used in the procedures
and their market demand as per their use, number of product launched,
annual revenue generated by products of each sub segment, trends in
industry, end user trend, and adoption rate across all the
geographies.
– Global Monoclonal Antibody
Therapeutics Market: Regional Outlook
Market share analysis among the market players is
analyzed to signify the contribution of these players in the market
in terms of percentage share. All these factors will help the market
players to decide about the business strategies and plans to
strengthen their positions in the global market. Based on geography,
the market has been analyzed for major regions: North America,
Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The study also covers detailed country analysis contributing majorly
in the monoclonal antibody therapeutics market.
– Key Players Mentioned in this Report
are:
The report also profiles the major players in the
market and provides various attributes such as company overview,
financial overview, product portfolio, business strategies, and
recent developments. Major companies profiled in the monoclonal
antibody therapeutics market are Bayer AG, F. Hoffmann-La Roche Ltd.,
Pfizer Inc., Sanofi, GlaxoSmithKline Plc., Merck & Co., Inc.,
Novartis AG, AbbVie Inc., Amgen Inc., Johnson & Johnson, Bristol
– Myers Squibb Company and Biogen Inc. .
** The monoclonal antibody therapeutics market
has been segmented as follows:
– Monoclonal Antibody Therapeutics
Market, by Application
- Cancer
- Autoimmune diseases
- Infection
- Hematological diseases
- Ophthalmological diseases
- Others
– Monoclonal Antibody Therapeutics
Market, by Source
- Human
- Humanized
- Chimeric
- Others
– Monoclonal Antibody Therapeutics
Market, by End Users
- Hospitals
- Private Clinics
- Research Institute
– Monoclonal Antibody Therapeutics
Market, by Geography
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Europe
- U.K.
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- India
- Japan
- China
- Australia
- New Zealand
- Rest of Asia Pacific
- Middle East and Africa
- South Africa
- Saudi Arabia
- A.E.
- Rest of MEA
Comments
Post a Comment